Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) EBIT Margin Growth (5y) (2024 - 2025)

Analysis

Evotec SE (EVO) EBIT Margin Growth (5y) (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn
6 Evotec SE 661.34 Mn 235.46 Mn -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn
10 VivoSim Labs 1.47 Mn 1.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 524.00
Sep 30, 2025 -1.27 Mn
Dec 31, 2024 -1,260.00